Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retina | 5 | 2019 | 50 | 2.780 |
Why?
|
Tomography, Optical Coherence | 5 | 2019 | 42 | 1.820 |
Why?
|
Visual Acuity | 4 | 2019 | 66 | 1.540 |
Why?
|
Retinal Vessels | 2 | 2019 | 18 | 1.430 |
Why?
|
Fluorescein Angiography | 5 | 2019 | 16 | 1.390 |
Why?
|
Alzheimer Disease | 2 | 2018 | 312 | 1.010 |
Why?
|
Vision Disorders | 2 | 2018 | 20 | 0.830 |
Why?
|
Macular Degeneration | 2 | 2018 | 21 | 0.760 |
Why?
|
Choroid | 1 | 2019 | 3 | 0.730 |
Why?
|
Choroidal Neovascularization | 1 | 2019 | 3 | 0.730 |
Why?
|
Retinal Diseases | 1 | 2019 | 18 | 0.700 |
Why?
|
Anemia, Sickle Cell | 1 | 2019 | 39 | 0.700 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2018 | 1 | 0.680 |
Why?
|
Eye Infections, Viral | 1 | 2018 | 3 | 0.680 |
Why?
|
Herpesvirus 1, Human | 1 | 2018 | 5 | 0.680 |
Why?
|
Herpes Simplex | 1 | 2018 | 12 | 0.680 |
Why?
|
Optic Nerve | 1 | 2018 | 8 | 0.660 |
Why?
|
Macula Lutea | 1 | 2018 | 9 | 0.650 |
Why?
|
Macular Edema | 1 | 2017 | 14 | 0.630 |
Why?
|
Peritoneal Dialysis | 1 | 2017 | 22 | 0.610 |
Why?
|
Conjunctiva | 1 | 2017 | 5 | 0.610 |
Why?
|
Eye Neoplasms | 1 | 2017 | 4 | 0.610 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2017 | 7 | 0.600 |
Why?
|
Cornea | 1 | 2017 | 15 | 0.600 |
Why?
|
Colitis, Ulcerative | 1 | 2017 | 20 | 0.600 |
Why?
|
Diabetic Retinopathy | 1 | 2017 | 64 | 0.600 |
Why?
|
Epithelial Cells | 1 | 2017 | 138 | 0.560 |
Why?
|
Child, Preschool | 4 | 2019 | 1167 | 0.520 |
Why?
|
Ophthalmology | 1 | 2013 | 4 | 0.470 |
Why?
|
Glaucoma, Open-Angle | 1 | 2013 | 17 | 0.460 |
Why?
|
Guideline Adherence | 1 | 2013 | 110 | 0.440 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 518 | 0.440 |
Why?
|
Continuity of Patient Care | 1 | 2013 | 64 | 0.440 |
Why?
|
Child | 4 | 2019 | 2219 | 0.430 |
Why?
|
Delivery of Health Care | 1 | 2013 | 142 | 0.410 |
Why?
|
Humans | 12 | 2019 | 29147 | 0.400 |
Why?
|
Brain | 1 | 2018 | 930 | 0.400 |
Why?
|
Infant | 3 | 2019 | 969 | 0.400 |
Why?
|
Adolescent | 4 | 2019 | 3257 | 0.390 |
Why?
|
Female | 8 | 2019 | 18189 | 0.370 |
Why?
|
Internship and Residency | 1 | 2013 | 283 | 0.350 |
Why?
|
Retinal Detachment | 2 | 2019 | 8 | 0.340 |
Why?
|
Male | 7 | 2019 | 17832 | 0.330 |
Why?
|
Angiogenesis Inhibitors | 2 | 2017 | 34 | 0.300 |
Why?
|
Retrospective Studies | 3 | 2019 | 3112 | 0.280 |
Why?
|
Fundus Oculi | 1 | 2019 | 11 | 0.180 |
Why?
|
Follow-Up Studies | 2 | 2017 | 2111 | 0.180 |
Why?
|
Capillaries | 1 | 2019 | 23 | 0.180 |
Why?
|
Hemoglobin, Sickle | 1 | 2019 | 7 | 0.180 |
Why?
|
Eye Enucleation | 1 | 2019 | 4 | 0.170 |
Why?
|
Paraffin Embedding | 1 | 2019 | 10 | 0.170 |
Why?
|
Cryosurgery | 1 | 2019 | 19 | 0.170 |
Why?
|
Organ Size | 1 | 2019 | 196 | 0.170 |
Why?
|
Foscarnet | 1 | 2018 | 1 | 0.170 |
Why?
|
Fibrosis | 1 | 2019 | 103 | 0.170 |
Why?
|
Laser Therapy | 1 | 2019 | 52 | 0.170 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 172 | 0.160 |
Why?
|
Atrophy | 1 | 2018 | 51 | 0.160 |
Why?
|
Antiviral Agents | 1 | 2018 | 100 | 0.160 |
Why?
|
Forecasting | 1 | 2018 | 133 | 0.160 |
Why?
|
Methylprednisolone Hemisuccinate | 1 | 2017 | 1 | 0.150 |
Why?
|
Mesalamine | 1 | 2017 | 2 | 0.150 |
Why?
|
Laser Coagulation | 1 | 2017 | 12 | 0.150 |
Why?
|
Prednisone | 1 | 2017 | 43 | 0.150 |
Why?
|
Drug Combinations | 1 | 2017 | 86 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 103 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 71 | 0.140 |
Why?
|
Glucocorticoids | 1 | 2017 | 149 | 0.140 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 493 | 0.130 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 1362 | 0.130 |
Why?
|
Adult | 2 | 2018 | 8441 | 0.130 |
Why?
|
Disease Progression | 1 | 2017 | 572 | 0.130 |
Why?
|
Aged | 2 | 2018 | 9494 | 0.130 |
Why?
|
Middle Aged | 2 | 2018 | 10846 | 0.120 |
Why?
|
Prospective Studies | 1 | 2019 | 2021 | 0.120 |
Why?
|
Academies and Institutes | 1 | 2013 | 5 | 0.120 |
Why?
|
Cohort Studies | 1 | 2017 | 1688 | 0.110 |
Why?
|
Societies, Medical | 1 | 2013 | 149 | 0.110 |
Why?
|
Oxidants | 1 | 2012 | 15 | 0.110 |
Why?
|
Retinal Pigment Epithelium | 1 | 2012 | 18 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2013 | 252 | 0.100 |
Why?
|
Treatment Outcome | 1 | 2017 | 3105 | 0.090 |
Why?
|
United States | 1 | 2013 | 3636 | 0.060 |
Why?
|
Animals | 1 | 2012 | 7300 | 0.010 |
Why?
|